Nanotechnology Now

Our NanoNews Digest Sponsors
Heifer International



Home > Press > Nanopoint's Far Eastern Clients to be Well-Served by a Network of Experienced, Regional Distributors Throughout Asia

Abstract:
Nanopoint, Inc. has announced its strong network of Asian distributors who include DayMoon Industries of Korea;, DI Biotech LTD of Korea; JC Biotech of Korea; JK Bio of Delhi, India; Joagene BioScience of Korea, Quantum Design China of China; Quantum Design Japan of Japan; and Trade 21 Pte., LTD of Singapore and SinWan Biotech LTD of Taiwan.

Nanopoint's Far Eastern Clients to be Well-Served by a Network of Experienced, Regional Distributors Throughout Asia

Honolulu, HI | Posted on April 23rd, 2008

Nanopoint Inc., an award-winning developer of cellTRAY® Fluidics and Imaging System products, is announcing the strong network of Asian distributorships the Company is building in order to provide the best-of-the-best customer sales and service in the expanding life science markets throughout the Far East. Nanopoint's carefully selected distributors in Korea, India, China, Japan, Singapore and Taiwan will bring their valuable understanding of Asia's diverse commercial cultures and help to expand the end-user base of the Company's total range of cellTRAY products. Nanopoint's level of precision for studying live cells is not available in any other commercially available live cell imaging system. The Asian distributors announced to-date include DayMoon Industries of Korea;, DI Biotech LTD of Korea; JC Biotech of Korea; JK Bio of Delhi, India; Joagene BioScience of Korea, Quantum Design China of China; Quantum Design Japan of Japan; and Trade 21 Pte., LTD of Singapore and SinWan Biotech LTD of Taiwan.

"We are honored that Nanopoint has contracted with such an outstanding group of distributors to represent us in Asia. In today's global marketplace, it's vitally important for us to have representatives on-the-ground who understand and respect the business culture of our clients and who deeply understand the technical specifications and benefits of our cellTRAY family of products," said Cathy Owen, Nanopoint's CEO. "Nanopoint is building a global brand; our headquarters in Hawaii provides a strong geographic base for building strategic market share in Asia as well as in the West--including the Americas and Europe."

Nanopoint is building a global brand; our headquarters in Hawaii provides a strong geographic base for building strategic market share in Asia as well as in the West--including the Americas and Europe.

In June 2008, Nanopoint will formally launch its cellTRAY® Imaging System Model CT-2000 and make its cellTRAY Fluidics System Model CT-2000F commercially available for purchase. Nanopoint's cellTRAY® Imaging System Model CT-2000 adds in all the precision navigation and image acquisition capabilities for drug screening and targeted nanoparticle delivery applications. The Model CT-2000 offers the most advanced, on-microscope, environmental control system available. The system allows experiments to run on an inverted microscope for extended periods of time, enabling time-lapse imaging of live cells over the course of several days.

Nanopoint's cellTRAYs have been carefully designed to enable scientists to easily move from a Petri dish or microtiter plate style of research to a more precise live cell imaging system. Each of the products has been designed to allow a methodical migration to a miniaturized research platform starting with the cellTRAY, a microscope slide-sized high precision etched well device that can be used with any laboratory equipment supporting slides, to the cellTRAY Imaging System Model CT-1000 which is an add-on to an upright or inverted microscope, to the cellTRAY Fluidics System Model CT-2000F and the cellTRAY Imaging System Model CT-2000 which can be easily added to an inverted microscope. Nanopoint's proprietary software provides the navigation, camera, shutter and filter controls, auto-focus, and microfluidics control necessary for today's demanding live cell imaging applications.

####

About Nanopoint, Inc.
Nanopoint, Inc. is a privately-held nano-biotechnology company that is revolutionizing the study and treatment of diseases with its live cell imaging solutions. Nanopoint's cellTRAY Fluidics and Imaging System products have broad applications to life science research, drug discovery, and biopharmaceutical production as well as other areas where live cell analysis is important.

For more information, please click here

Contacts:
Corporate Contact:
Ken Perel
Nanopoint, Inc.
kperel(at)nanopointimaging.com
808-457-1145 Phone
808-537-4245 Fax

Media Contact:
Sandra Kay Helsel, Ph.D.
SK Helsel & Associates
www.skhelsel.com
skhelsel(at)skhelsel.com
520-325-4636 Office
520-390-8184 Cell

Copyright © PRWeb™

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

Imaging

New material to make next generation of electronics faster and more efficient With the increase of new technology and artificial intelligence, the demand for efficient and powerful semiconductors continues to grow November 8th, 2024

News and information

Beyond wires: Bubble technology powers next-generation electronics:New laser-based bubble printing technique creates ultra-flexible liquid metal circuits November 8th, 2024

Nanoparticle bursts over the Amazon rainforest: Rainfall induces bursts of natural nanoparticles that can form clouds and further precipitation over the Amazon rainforest November 8th, 2024

Nanotechnology: Flexible biosensors with modular design November 8th, 2024

Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024

Nanomedicine

Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024

NYU Abu Dhabi researchers develop novel covalent organic frameworks for precise cancer treatment delivery: NYU Abu Dhabi researchers develop novel covalent organic frameworks for precise cancer treatment delivery September 13th, 2024

Unveiling the power of hot carriers in plasmonic nanostructures August 16th, 2024

Nanobody inhibits metastasis of breast tumor cells to lung in mice: “In the present study we describe the development of an inhibitory nanobody directed against an extracellular epitope present in the native V-ATPase c subunit.” August 16th, 2024

Announcements

Nanotechnology: Flexible biosensors with modular design November 8th, 2024

Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024

Turning up the signal November 8th, 2024

Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024

Alliances/Trade associations/Partnerships/Distributorships

Manchester graphene spin-out signs $1billion game-changing deal to help tackle global sustainability challenges: Landmark deal for the commercialisation of graphene April 14th, 2023

Chicago Quantum Exchange welcomes six new partners highlighting quantum technology solutions, from Chicago and beyond September 23rd, 2022

CEA & Partners Present ‘Powerful Step Towards Industrialization’ Of Linear Si Quantum Dot Arrays Using FDSOI Material at VLSI Symposium: Invited paper reports 3-step characterization chain and resulting methodologies and metrics that accelerate learning, provide data on device pe June 17th, 2022

University of Illinois Chicago joins Brookhaven Lab's Quantum Center June 10th, 2022

NanoNews-Digest
The latest news from around the world, FREE




  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project